Study examines risk factors for severe health problems in kids with COVID-19
An international study involving researchers at Washington University School of Medicine analyzed the risk factors for serious health outcomes in kids who had COVID-19. Researchers found that children up to age 18 who had tested positive for COVID-19 were at low risk for severe health problems.
U.S. drug prices are costing us more than we think
Aduhelm, the first new Alzheimer’s drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works.
How distance from care affects cancer outcomes
In a seemingly counterintuitive finding, young adults diagnosed with central nervous system tumors might have better survival rates the farther they live from care, finds a new Brown School study.
Infectious disease initiative launches
The Brown School, the Institute for Public Health’s Center for Dissemination and Implementation and the School of Medicine’s Infectious Disease Division have launched the Infectious Disease Dissemination and Implementation Science (IDDI) Initiative.
COVID-19 boosters: An update with experts Lawrence and LeBlanc
Steven Lawrence, MD, an infectious disease specialist at the School of Medicine, and Cheri LeBlanc, MD, executive director of the Habif Health & Wellness Center on the Danforth Campus, explain how booster shots work, why the university is not requiring boosters at this time and the outlook for COVID on campus.
Warning labels on soda bottles, restaurant menus could reduce obesity, save health-care costs
Warning labels on sugar-sweetened beverages and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School.
Environmental injustice, population density and the spread of COVID-19 in minority communities
Research from the lab of Rajan Chakrabarty at the McKelvey School of Engineering connects environmental injustice to the spread of COVID-19 in communities with high minority populations.
Pediatric COVID-19 vaccine trial underway
A pediatric COVID-19 vaccine clinical trial is underway in St. Louis. Led by Washington University School of Medicine, about 140 area children will receive the two-shot Moderna vaccine or a placebo at St. Louis Children’s Hospital as part of a clinical trial involving about 100 medical institutions in the U.S. and Canada.
Diabetes research center receives $4.3 million NIH grant
The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health (NIH), has awarded $4.3 million to renew the Washington University Center for Diabetes Translation Research.
Ssewamala receives $3.2M to address HIV stigma among Ugandan teens
Fred Ssewamala, the William E. Gordon Distinguished Professor at the Brown School, has received a grant to study the impact of a multilevel intervention to reduce HIV stigma and improve treatment outcomes among adolescents in Uganda.
Older Stories